Lisa Fazzini

Plain English
This study looked at the use of a type of heart medication called dihydropyridine calcium channel blockers (DHP-CCB) in patients with heart failure, focusing on their impact based on how well the heart pumps blood (ejection fraction). Out of nearly 15,800 patients studied, only 9.1% were prescribed DHP-CCB, which was more common in patients with a better heart function (13.9% for those with ejection fraction over 40% compared to 7.1% for those with reduced function). The findings show that DHP-CCB use is linked to worse health outcomes and lower rates of standard heart failure treatments, emphasizing the need for more research on their safety, especially in those with reduced heart function. Who this helps: This research helps doctors and patients with heart failure by highlighting concerns over specific medications.

Plain English
This study examined 94 patients with acute myocarditis to see how their heart images from a special MRI (called cardiovascular magnetic resonance) related to their symptoms. They found that patients with more severe symptoms had higher levels of heart damage markers, lower heart function, and specific heart strain patterns. Importantly, a certain type of heart imaging called septal late gadolinium enhancement identified patients who were at a higher risk for complications. Who this helps: This research helps doctors understand which myocarditis patients are at greater risk and may need more intensive care.

Plain English
This research examined how exposure to tiny air particles from shipping activities affects heart health in people near ports. The study found that these particles can significantly change heart rate variability, indicating stress on the heart, particularly showing that exposure can reduce the activity of the body's rest-and-repair system. At times, particle concentrations reached up to 7 million particles per cubic centimeter, especially during ship docking. Who this helps: This helps residents and workers in port areas concerned about heart health.

Plain English
This study looked at how using genetic testing to guide the selection of blood-thinning medications affects patients with acute coronary syndrome (ACS) who undergo procedures to open blocked arteries. Researchers found that while there were no major differences in overall safety or effectiveness after one year, using genetic testing to adjust medication reduced the risk of heart attacks and bleeding complications in the first three months after the procedure. This matters because it shows that tailoring treatment based on a person's genetics can lead to better short-term outcomes for patients. Who this helps: Patients with acute coronary syndrome undergoing artery-opening procedures.

Plain English
This study looked at patients hospitalized for heart failure with preserved ejection fraction (HFpEF) to better understand their recovery and risks after discharge. Researchers found that among 471 patients, there were three distinct groups: younger patients with fewer health issues (low risk), elderly women with hypertension (intermediate risk), and older patients with worsening heart failure and other health complications (high risk). The high-risk group was five times more likely to face severe outcomes like death or hospitalization within a year compared to the low-risk group. Who this helps: This research benefits doctors and healthcare providers by helping them better manage their patients' care after hospitalization.

Plain English
This study looked at patients with systemic lupus erythematosus (SLE) to understand how changes in their metabolism and heart function could predict disease progression. Over six years, researchers found that even though some heart measurements appeared normal, subtle changes in the right side of the heart were happening, especially in patients whose condition worsened. They discovered that certain metabolites in the blood, specifically higher levels of 2-aminoheptanedioic acid, were linked to these deteriorations in health. Who this helps: This helps SLE patients by identifying those at risk for heart issues early on.

Plain English
This study looked at how effective ACE inhibitors are in protecting the heart from damage caused by a common type of cancer treatment called anthracycline chemotherapy. Researchers reviewed data from 7 trials with 686 patients and found that those taking ACE inhibitors had a 5% smaller decline in heart function compared to those who did not take them. This is important because it suggests that ACE inhibitors can help maintain better heart health during cancer treatment, especially for patients also receiving another drug called trastuzumab. Who this helps: This research benefits cancer patients, particularly those being treated with anthracyclines and trastuzumab.

Plain English
This study looked at two ways of measuring how well the heart's left ventricle is working: echocardiography and cardiac magnetic resonance imaging. Researchers found a moderate overall correlation of 57% between the two methods, but this correlation was weaker in healthy individuals (38%) and stronger in those with cardiovascular disease (62%). This is important because it helps doctors understand how to interpret these two measurement methods across different patient groups without assuming they can be used interchangeably. Who this helps: Patients with heart conditions and their doctors.

Plain English
This study looked at three different methods for repairing complex aortic aneurysms: fenestrated, branched, and chimney endovascular repairs. It found that while all methods improved blood flow after surgery, the branched repair had the highest flow rates and fewer areas of problematic blood flow. The fenestrated repair provided more stable flow patterns, while the chimney repair offered streamlined flow with less backflow at junctions. This research matters because it helps doctors understand which repair method may work best for maintaining healthy blood flow in patients with complex aortic aneurysms. Who this helps: Patients with complex aortic aneurysms and their doctors.

Plain English
This study looked at the use of home-based treatments called inotropic therapy for patients with advanced heart failure, focusing on medications like dobutamine and milrinone. The findings showed that these treatments can improve patients' quality of life, decrease hospital visits, and help keep patients stable. This is important because it offers a way to help manage advanced heart failure for those who cannot have surgeries like heart transplants. Who this helps: Patients with advanced heart failure and their caregivers.

Plain English
This study looked at how often a specific kind of heart damage, detected by heart imaging called late gadolinium enhancement (LGE), occurs in patients with Takotsubo syndrome (TTS), a temporary heart condition often triggered by stress. Researchers found that 22.4% of TTS patients showed LGE, but this rate increased to 40.7% if images were taken within 3 days of their symptoms starting. This information is important because it helps doctors understand how timing and testing methods can affect the diagnosis and treatment of TTS. Who this helps: This benefits patients with Takotsubo syndrome and their doctors.

Plain English
This study looked at patients who showed a drop in heart function during exercise, even though they didn't have blocked arteries. Out of over 213,000 exercise stress tests done over nearly two decades, 134 patients met the criteria, showing a decrease in heart function from an average of 58% at rest to 43% during peak exertion. The findings revealed that over ten years, about 17.6% of these patients were likely to be hospitalized for heart failure, and 12.9% were expected to die, mostly from non-heart-related causes. Who this helps: This information is useful for doctors and patients who may need better understanding and management of heart function during exercise.

Plain English
This study looked at the safety of giving crushed or chewed P2Y12 inhibitors to patients experiencing acute coronary syndrome (ACS), which is a type of heart problem. They analyzed data from nine clinical trials involving 1,091 patients and found that using these medications in this way did not lead to more bleeding events or serious heart issues compared to taking them whole. Specifically, the overall risk of major bleeding was very low: 0.36% for crushed/chewed and 0.95% for whole pills, which shows that this method is safe and effective for quicker treatment. Who this helps: This research benefits patients with acute coronary syndrome and doctors treating them.

Plain English
This study looked at how immune checkpoint inhibitors (ICIs), which are treatments for cancer, can cause heart problems like atrioventricular blocks (AVB). Researchers found that most patients who developed these issues were older men with advanced lung or kidney cancers, experiencing AVB within three weeks of starting treatment. In serious cases, these heart problems required stopping the treatment and could lead to death, with less than half of patients recovering fully. Who this helps: This information benefits cancer patients and their doctors by highlighting potential heart risks from a common treatment.

Plain English
This study looked at the MitraClip procedure, which is a treatment for patients with severe heart failure and a condition called mitral regurgitation, where the heart valve does not close properly. The researchers presented a successful case where a patient with serious heart issues received the MitraClip and found that this approach can be effective in these difficult situations. This matters because it offers a new option for patients who are struggling with advanced heart failure and need immediate help. Who this helps: This helps patients with advanced heart failure and severe mitral regurgitation.

Plain English
This study looked at how certain genetic traits in cancer patients can increase the risk of heart problems caused by cancer treatments. It found that specific genetic markers can help identify patients who are more likely to experience serious side effects from these therapies, making it easier to provide them with better care. For instance, genetic factors improve the ability to pinpoint patients at higher risk, allowing for more tailored treatment and monitoring. Who this helps: Patients undergoing cancer treatment who are at risk for heart issues.

Plain English
This study looked at patients with Takotsubo syndrome (a temporary heart condition often caused by stress) to see how common amyotrophic lateral sclerosis (ALS) is among them and how it affects their health. Out of 85 patients, 6 (or 7%) had ALS. Those with ALS had more serious heart issues during their hospital stay and faced a much higher risk of death over an average follow-up of 6 years, with a mortality rate nearly 19 times higher than those without ALS. Who this helps: This information is beneficial for doctors treating patients with both Takotsubo syndrome and ALS.

Plain English
This study looked at how the relationship between heart function and blood vessel conditions (called left ventricular-arterial coupling) affects patient survival in a cardiac intensive care unit. Researchers found that among nearly 4,700 patients, those with a higher VAC ratio had a 63% greater chance of dying in the hospital compared to those with a lower ratio. This is important because it shows that measuring this ratio can help doctors identify patients at higher risk for severe outcomes. Who this helps: This helps doctors in the cardiac intensive care unit better assess and manage patient risks.

Plain English
This study looked at how hemoadsorption, a treatment that filters blood to remove harmful substances, affects men and women undergoing heart surgery for infections. Researchers found that using hemoadsorption did not significantly change organ function or reduce the likelihood of dying within 30 days after surgery for either sex. These findings are important because they suggest that this treatment may not provide the expected benefits for patients after heart surgery. Who this helps: This helps doctors understand the effectiveness of hemoadsorption in treating patients with infective endocarditis.

Plain English
This study focused on how exercise can benefit cancer patients, especially those experiencing heart issues either from their illness or from chemotherapy side effects. It found that exercise helps maintain heart function and overall physical ability in these patients. These findings highlight the importance of prescribing exercise as part of cancer treatment, which can improve patients' quality of life and health outcomes. Who this helps: This helps cancer patients and doctors developing treatment plans.

Plain English
This study looked at family members of patients with hereditary transthyretin amyloid cardiomyopathy (ATTRv-CM) who had not been diagnosed before. Out of 85 participants, most were around 48 years old and only a small percentage showed heart problems over a follow-up period of about 6.8 years, while 25.5% developed nerve-related issues like peripheral neuropathy. These findings suggest that family members may experience more neurological symptoms than heart issues, highlighting the need for early detection and treatment to prevent complications. Who this helps: This helps patients and their families by providing important information for early diagnosis and treatment.

Plain English
This research paper looks at how the human papillomavirus (HPV) may be linked to rare growths in the esophagus called esophageal squamous papilloma and papillomatosis. The findings indicate that while these growths usually aren’t cancerous, they can be associated with high-risk types of HPV and a possible chance of turning into cancer, especially in cases with multiple lesions or positive HPV results. Understanding these links is crucial for developing better ways to detect, monitor, and treat these conditions effectively. Who this helps: This benefits patients with esophageal lesions and their doctors by providing clearer guidelines for monitoring and treatment options.

Plain English
This study looked at the role of a protein called interleukin-6 (IL-6) in cardiogenic shock, which is a severe condition that can occur during heart problems and is associated with high death rates. It found that high levels of IL-6 are linked to worse outcomes for patients, including higher chances of organ failure and death. Understanding IL-6's role may lead to new treatment options that could improve survival for patients with this serious condition. Who this helps: This helps patients experiencing cardiogenic shock and their doctors.

Plain English
This study looked at how home inotropes—medications that help the heart pump better—can benefit patients with advanced heart failure, a serious condition that often leads to hospitalization and poor quality of life. The review found that using these medications at home can improve patients' everyday living and may help prevent hospital stays, especially for those waiting for heart transplants or other treatments. This matters because many patients with advanced heart failure don't qualify for intensive treatments and need alternatives to manage their condition effectively. Who this helps: This helps patients with advanced heart failure who are not candidates for heart transplants or other major therapies.

Plain English
This research paper reviews various strategies to prevent heart problems that can arise from cancer treatments. It highlights that some medications, like the FDA-approved drug dexrazoxane, can protect patients receiving certain chemotherapy drugs, while lifestyle changes such as exercise and a healthy diet are also recommended for improving heart health. The findings underscored that a combined approach—using both medications and lifestyle changes—is crucial for protecting the heart of cancer patients. Who this helps: This benefits cancer patients undergoing treatment.

Plain English
This study looked at how a biomarker called soluble suppression of tumorigenicity-2 (sST2) changes during cancer treatments that can harm the heart. Researchers found that sST2 levels increased from the start of treatment to the follow-up, but decreased at a later stage after chemotherapy. They also found that higher sST2 levels were linked to worse heart function, measured by a drop in the heart's pumping efficiency, with a correlation of about -0.29. Who this helps: This research benefits patients undergoing cancer treatments that can cause heart problems.

Plain English
The study looked at a type of heart disease called hypokinetic nondilated cardiomyopathy (HNDC) and compared it to the more common dilated cardiomyopathy (DCM). Researchers found that of 1,748 patients studied, 568 (32.5%) had HNDC, which is often less severe than DCM; for example, fewer HNDC patients experienced serious health issues like death or hospitalization for heart failure (12.5% compared to 17.1% for DCM). This matters because understanding HNDC's distinct characteristics can lead to better treatment approaches, particularly since beta-blockers showed significant benefits for HNDC patients. Who this helps: Patients with hypokinetic nondilated cardiomyopathy and their doctors.

Plain English
This study examined the side effects of a drug called sodium nitroprusside (SNP) in a patient with severe heart failure. The researchers found that after several weeks of high doses, the patient developed dangerous heart rhythm issues due to low levels of calcium, likely caused by a toxic buildup of another compound called thiocyanate. By lowering the SNP dosage, they were able to normalize calcium levels and reduce the risk of dangerous heart rhythms, allowing the patient to proceed with a heart transplant. Who this helps: Patients with severe heart failure receiving SNP treatment.

Plain English
This study looked at how heart failure (HF) affects men and women differently. It found that women are more likely to have HF with preserved ejection fraction, and common health issues like diabetes and high blood pressure play a significant role in their condition. Understanding these differences is important because it helps ensure that treatments are better tailored to each gender's specific needs. Who this helps: This helps patients with heart failure, particularly women.

Plain English
This study looked at how two surgical techniques, fenestrated endovascular aortic repair (FEVAR) and chimney endovascular aortic repair (ChEVAR), affected blood flow in patients with complex aortic aneurysms. Researchers analyzed data from three patients for each method and found that both surgeries improved blood flow, with less turbulence and a lower chance of blood clots post-surgery. Specifically, ChEVAR showed signs of better blood flow patterns compared to FEVAR, with less recirculation near certain arteries. Who this helps: This benefits patients with complex aortic aneurysms by offering more effective treatment options.

Plain English
This study looked at how to better identify people at risk for heart failure who do not yet show symptoms but have a measurement of heart function above 40%. Researchers analyzed data from 596 patients, finding that those in a specific high-risk group—Cluster 3—were older and had significantly worse health outcomes, including a 2.5 times higher risk of experiencing heart failure or death compared to lower-risk groups. This matters because targeting preventive care to this high-risk group could help avoid serious heart-related problems down the line. Who this helps: Patients with preclinical heart failure and their doctors.

Plain English
This study looks at how a heart condition called patent foramen ovale (PFO) affects vision and can lead to various eye problems. Researchers found that PFO can cause issues like temporary vision changes and eye infections, which can prompt patients to visit eye doctors. Understanding these problems is key to improving treatment and reducing the impact of PFO on patients’ health. Who this helps: This helps patients experiencing eye problems related to PFO and the doctors treating them.

Plain English
This study looked at how gait speed, or how quickly patients walk, can predict outcomes for patients with worsening heart failure, a serious condition. Researchers found that among 171 older patients, those with a slower gait speed (0.8 meters per second or less) had a much higher risk of dying or being hospitalized due to heart failure, with a hazard ratio of 4.03, meaning they were over four times more likely to face these issues. By including gait speed in risk assessments, doctors can better gauge how patients will fare, which is important for guiding treatment and care. Who this helps: This helps doctors identify high-risk heart failure patients and manage their treatment more effectively.

Plain English
This study looked at the connection between amyotrophic lateral sclerosis (ALS) and Takotsubo syndrome (TTS) in a group of patients from Sardinia, Italy. Out of 344 ALS patients observed over ten years, 5 (or about 1.45%) developed TTS, all of whom were women with an average age of about 71.5 years, and they were at an advanced stage of ALS when diagnosed. Understanding this relationship is important because it highlights specific risk factors for TTS in ALS patients, which could improve patient care and treatment. Who this helps: This helps patients with ALS and their doctors by identifying potential cardiac risks.

Plain English
This research study looks at how echocardiography, a type of ultrasound used to visualize the heart, plays a vital role in managing patients with advanced heart failure (AdHF). Advanced heart failure is serious, with about 50% of patients facing death within a year, but echocardiography can help doctors tailor treatments effectively and spot patients at higher risk. Understanding and using echocardiography can improve patient outcomes and potentially delay the need for more extreme treatments like heart transplants. Who this helps: This helps patients with advanced heart failure and their doctors.

Plain English
This research reviews how genetic markers relate to heart failure (HF) and what they mean for treatment. It found that genetic testing can help diagnose HF, predict how a patient will do, and identify ways to tailor treatments based on individual genetic profiles. With heart failure becoming more common, especially in older people, understanding these genetic factors is crucial for improving patient care and outcomes. Who this helps: This benefits patients with heart failure and their doctors by guiding personalized treatment strategies.

Plain English
This study looked at two types of lung surgery—video-assisted thoracoscopic surgery (VATS) and open thoracotomy (OT)—to see which is better for patients with lung metastases. Researchers found that patients who had VATS had higher overall survival rates (75% less risk of death compared to OT) and spent about 2 days less in the hospital without seeing a difference in how often their cancer came back. This matters because it shows that VATS can lead to better outcomes for patients while also shortening their recovery time. Who this helps: This benefits patients undergoing lung surgery for cancer.

Plain English
This study looked at patients who underwent two different heart valve replacement procedures: Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR). It found that patients who had TAVI were less likely to experience postoperative delirium, with only 35 out of every 100 patients affected compared to 100 out of every 100 for SAVR. This is important because minimizing delirium can lead to better recovery and overall outcomes for patients after heart surgery. Who this helps: Patients undergoing heart valve replacement procedures.

Plain English
This study looked at how well patients used a wearable heart device meant to prevent sudden cardiac death. Out of 25 patients, 84% were men with an average age of 63.6 years, and they wore the device for about 90 days for almost 24 hours each day. The results showed that 24% of the patients ended up needing a different heart device due to significant differences in heart function between those who switched to an implanted device and those who did not. Who this helps: This helps patients with heart conditions who may need a wearable device for protection.

Plain English
This research paper looks at how certain cancer treatments can harm the heart, a condition known as cardiomyopathy. The study reviews various investigations that analyze metabolic changes in the body, which may help predict heart problems caused by these treatments. Understanding these metabolic profiles is important because it can lead to earlier diagnosis and better protective measures for patients undergoing chemotherapy. Who this helps: This helps cancer patients and their doctors by improving heart health monitoring during treatment.

Plain English
This study looks at a rare condition called "happy heart syndrome," which can occur when people experience strong positive emotions, like joy from a sporting victory. The researchers treated a 52-year-old woman with this condition and highlighted how it differs from the more common "Takotsubo syndrome," which is usually linked to negative stress. It's important for doctors to recognize happy heart syndrome since it can be misdiagnosed and can be related to other health issues like hyperthyroidism. Who this helps: This helps patients who have experienced significant positive emotions and may be at risk for this rare syndrome.

Plain English
This study looked at using tiny molecules called microRNAs found in blood to improve screening for colorectal cancer (CRC). Researchers tested blood samples from people with positive fecal tests and identified specific microRNA patterns that could indicate the presence of early-stage cancer or precursors. These blood-based tests showed promising accuracy, with areas under the curve ranging from 0.644 to 0.682 for detecting different types of lesions, which could help target colonoscopy procedures to those who need them most. Who this helps: This benefits patients by providing a less invasive screening option and helps doctors identify those who are at higher risk for colorectal cancer.

Plain English
The study looked at two methods of preparing for a late-morning colonoscopy: one involved taking a smaller amount of a cleansing solution (2-L PEG-citrate-simethicone) with additional tablets, while the other used a larger amount (4-L PEG) taken in two doses. Both methods were found to be equally effective for cleaning the bowels, with 89.7% success for the smaller solution and 92.1% for the larger one, and the visibility of the colon during examination was better with the smaller solution (85.7% vs. 72.4%). This research matters because it shows that a less burdensome preparation can still work well, allowing patients to maintain their normal activities before the procedure. Who this helps: Patients preparing for colonoscopies.

Plain English
This study looked at a mold called Penicillium decumbens, which was found in a water-damaged building, to understand how it produces a chemical called (+)-thujopsene. Researchers discovered that this mold produces more (+)-thujopsene when it grows at 30°C and 100% humidity, and they found that this chemical can inhibit the growth of some other mold strains. These findings are important because they can help us understand how molds interact with each other and how to manage indoor air quality better. Who this helps: This helps homeowners, building managers, and health professionals dealing with mold-related issues.